📊 CDTTW Key Takeaways
Is CDT Equity Inc. (CDTTW) a Good Investment?
CDT Equity is a pre-revenue pharmaceutical company with severe cash burn and negative profitability across all metrics. The company is burning approximately $11.3M in free cash flow annually with only $3.8M in cash reserves, creating a critical runway issue without additional financing.
CDT Equity Inc. shows very weak fundamentals: it appears pre-revenue or effectively non-commercial, with persistent operating and net losses, deeply negative returns on assets and equity, and materially negative free cash flow. While leverage is low and liquidity is still above 1x, the balance sheet is small relative to the current cash burn, making future dilution or external financing a significant risk unless the company can materially improve operating performance.
Why Buy CDT Equity Inc. Stock? CDTTW Key Strengths
- Modest long-term debt of only $200K limiting leverage risk
- Current ratio of 1.66x indicates adequate short-term liquidity
- Pharmaceutical sector positioning if clinical/regulatory milestones achieved
- Low financial leverage, with debt/equity of just 0.05x
- Current and quick ratios of 1.66x indicate near-term obligations are still covered
- Positive equity balance and $3.84M cash provide limited short-term operating flexibility
CDTTW Stock Risks: CDT Equity Inc. Investment Risks
- No revenue generation with complete dependence on cash reserves for operations
- Negative free cash flow of -$11.3M annually with only ~10 months of cash runway remaining
- Extreme negative returns (ROE -418.4%, ROA -209.3%) and operating margin of N/A indicating losses on minimal asset base
- Operating losses of -$15.6M and net losses of -$17.9M with deteriorating EPS
- Pre-clinical/early-stage status with no clear path to revenue or profitability
- No meaningful revenue base, making profitability and growth quality difficult to support
- Heavy annual losses and negative free cash flow imply a short cash runway relative to burn
- Extremely negative ROE and ROA indicate weak capital efficiency and high dependence on future funding
Key Metrics to Watch
- Monthly cash burn rate and runway to profitability or capital raise
- Clinical trial progress and regulatory milestones
- Insider buying/selling activity for signal of management confidence
- Operating loss trends and ability to extend cash runway
- Quarterly operating cash burn versus cash balance
- Any emergence of sustainable revenue or material narrowing of operating losses
CDT Equity Inc. (CDTTW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
CDT Equity Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
CDTTW Profit Margin, ROE & Profitability Analysis
CDTTW vs Healthcare Sector: How CDT Equity Inc. Compares
How CDT Equity Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is CDT Equity Inc. Stock Overvalued? CDTTW Valuation Analysis 2026
Based on fundamental analysis, CDT Equity Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
CDT Equity Inc. Balance Sheet: CDTTW Debt, Cash & Liquidity
CDTTW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: CDT Equity Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-61,598.62 indicates the company is currently unprofitable.
CDTTW Revenue Growth, EPS Growth & YoY Performance
CDT Equity Inc. Dividends, Buybacks & Capital Allocation
CDTTW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for CDT Equity Inc. (CIK: 0001896212)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CDTTW
What is the AI rating for CDTTW?
CDT Equity Inc. (CDTTW) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 90% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CDTTW's key strengths?
Claude: Modest long-term debt of only $200K limiting leverage risk. Current ratio of 1.66x indicates adequate short-term liquidity. ChatGPT: Low financial leverage, with debt/equity of just 0.05x. Current and quick ratios of 1.66x indicate near-term obligations are still covered.
What are the risks of investing in CDTTW?
Claude: No revenue generation with complete dependence on cash reserves for operations. Negative free cash flow of -$11.3M annually with only ~10 months of cash runway remaining. ChatGPT: No meaningful revenue base, making profitability and growth quality difficult to support. Heavy annual losses and negative free cash flow imply a short cash runway relative to burn.
What is CDTTW's revenue and growth?
CDT Equity Inc. reported revenue of N/A.
Does CDTTW pay dividends?
CDT Equity Inc. does not currently pay dividends.
Where can I find CDTTW SEC filings?
Official SEC filings for CDT Equity Inc. (CIK: 0001896212) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CDTTW's EPS?
CDT Equity Inc. has a diluted EPS of $-74.92.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CDTTW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, CDT Equity Inc. has a STRONG SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CDTTW stock overvalued or undervalued?
Valuation metrics for CDTTW: ROE of -418.4% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy CDTTW stock in 2026?
Our dual AI analysis gives CDT Equity Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CDTTW's free cash flow?
CDT Equity Inc.'s operating cash flow is $-10.9M, with capital expenditures of $398.0K.
How does CDTTW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -418.4% (avg: 15%), current ratio 1.66 (avg: 2).